Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy C Thompson

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Human Gene Therapy|June 14, 2003
Radiation improves intratumoral gene therapy for induction of cancer vaccine in murine prostate carcinomaGilda G Hillman, Minzhen Xu, Yu Wang, et al.
Current Drug Targets|March 20, 2003
Therapeutic targets for metastatic prostate cancerTerry L Timme, Takefumi Satoh, Salahaldin A Tahir, et al.
Chinese Journal of Cancer|January 24, 2018
Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinomaYan Liu, Xiaojie Tan, Wenbin Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2006
Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patientsTetsuo Fujita, Bin S Teh, Terry L Timme, et al.
The Journal of Pathology|June 5, 2013
Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progressionGustavo Ayala, Matteo Morello, Anna Frolov, et al.
Nature Reviews. Urology|April 7, 2021
Optimizing the diagnosis and management of ductal prostate cancerWeranja Ranasinghe, Daniel D Shapiro, Miao Zhang, et al.
Scientific Reports|May 27, 2016
A genetic polymorphism affects the risk and prognosis of renal cell carcinoma: association with follistatin-like protein 1 expressionYan Liu, Xue Han, Yongwei Yu, et al.
Cancer Research|October 26, 2011
GLIPR1 suppresses prostate cancer development through targeted oncoprotein destructionLikun Li, Chengzhen Ren, Guang Yang, et al.
Radiation Oncology (London, England)|April 19, 2011
The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivoYuanhong Gao, Hiromichi Ishiyama, Mianen Sun, et al.
Molecular Oncology|January 22, 2013
Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2Likun Li, Guang Yang, Chengzhen Ren, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Human Gene Therapy|June 14, 2003
Radiation improves intratumoral gene therapy for induction of cancer vaccine in murine prostate carcinomaGilda G Hillman, Minzhen Xu, Yu Wang, et al.
Current Drug Targets|March 20, 2003
Therapeutic targets for metastatic prostate cancerTerry L Timme, Takefumi Satoh, Salahaldin A Tahir, et al.
Chinese Journal of Cancer|January 24, 2018
Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinomaYan Liu, Xiaojie Tan, Wenbin Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2006
Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patientsTetsuo Fujita, Bin S Teh, Terry L Timme, et al.
The Journal of Pathology|June 5, 2013
Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progressionGustavo Ayala, Matteo Morello, Anna Frolov, et al.
Nature Reviews. Urology|April 7, 2021
Optimizing the diagnosis and management of ductal prostate cancerWeranja Ranasinghe, Daniel D Shapiro, Miao Zhang, et al.
Scientific Reports|May 27, 2016
A genetic polymorphism affects the risk and prognosis of renal cell carcinoma: association with follistatin-like protein 1 expressionYan Liu, Xue Han, Yongwei Yu, et al.
Cancer Research|October 26, 2011
GLIPR1 suppresses prostate cancer development through targeted oncoprotein destructionLikun Li, Chengzhen Ren, Guang Yang, et al.
Radiation Oncology (London, England)|April 19, 2011
The alkylphospholipid, perifosine, radiosensitizes prostate cancer cells both in vitro and in vivoYuanhong Gao, Hiromichi Ishiyama, Mianen Sun, et al.
Molecular Oncology|January 22, 2013
Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2Likun Li, Guang Yang, Chengzhen Ren, et al.
Pageof 12